4//SEC Filing
NEW ENTERPRISE ASSOCIATES 13 LP 4
Accession 0001209191-24-002497
CIK 0001400118other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:55 PM ET
Size
6.0 KB
Accession
0001209191-24-002497
Insider Transaction Report
Form 4
NEW ENTERPRISE ASSOCIATES 13 LP
10% Owner
Transactions
- Other
Series A Common Stock
2024-01-29−850,000→ 3,000,275 total
Footnotes (2)
- [F1]New Enterprise Associates 13, L.P. ("NEA 13") made a pro rata distribution of 850,000 shares of Series A Common Stock of the Issuer to its general partner and limited partners for no consideration on January 29, 2024.
- [F2]The securities are directly held by NEA 13 and are indirectly held by NEA Partners 13, L.P. ("NEA Partners 13"), the sole general partner of NEA 13, NEA 13 GP, LTD ("NEA 13 LTD"), the sole general partner of NEA Partners 13, and the individual directors of NEA 13 LTD (NEA Partners 13, NEA 13 LTD and the individual directors of NEA 13 LTD (collectively, the "Directors"), together, the "Indirect Reporting Persons"). The Directors of NEA 13 LTD are Forest Baskett, Patrick J. Kerins and Scott D. Sandell. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 13 in which the Indirect Reporting Persons have no pecuniary interest.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001452907
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:55 PM ET
- Size
- 6.0 KB